Role of Sialylated Glycans on Bovine Lactoferrin Against Influenza Virus

Overview

Journal Glycoconj J

Publisher Springer

Specialties Biochemistry
Endocrinology

Date 2021 Nov 15

PMID 34779975

Citations 5

Authors

Xilong Wang

Lixin Yue

Liuyi Dang

Jiajun Yang

Zhuo Chen

Xiurong Wang

Jian Shu

Zheng Li

Affiliations

Soon will be listed here.

Abstract

Influenza is a worldwide plague caused by the influenza virus (IAV) infection, which is initiated by specific recognition with sialic acids on host cell surface. Bovine lactoferrin (bLf) is a sialoglycoprotein belonging to the transferrin family, and it plays an important role in immune regulation. It also shows toxicity against cancer cells and pathogenic microorganisms including bacteria, fungi, and virus. The purpose of this study is to assess the roles of the sialylated glycans on bLf against IAV. To this end, bLf were first treated with sodium periodate to destroy its sialylated glycans. Then, the binding activity of native or desialylated bLf with various IAV was assessed by blotting assay. Finally, their ability to inhibit IAV attachment to host cells was analyzed in vitro. Our result showed that the sialylated glycans on bLf were almost completely destroyed by sodium periodate treatment. Furthermore, the binding activity of desialylated bLf to IAV and the ability to inhibit IAV mimics binding to MDCK cells were significantly reduced compared to that of native bLf. These results demonstrated that the sialylated glycans on bLf could serve as competitive substrates to block IAV attachment to host cells during the early stages of viral infection. Our findings make an important contribute for the fully understanding of the mechanism of bLf in the prevention of IAV infections and their possible applications in antiviral infection.

Citing Articles

The potential of lactoferrin as antiviral and immune-modulating agent in viral infectious diseases.

Eker F, Duman H, Erturk M, Karav S Front Immunol. 2024; 15:1402135.

PMID: 39620218 PMC: 11604709. DOI: 10.3389/fimmu.2024.1402135.

The Multifaceted Roles of Bovine Lactoferrin: Molecular Structure, Isolation Methods, Analytical Characteristics, and Biological Properties.

Dyrda-Terniuk T, Pomastowski P J Agric Food Chem. 2023; 71(51):20500-20531.

PMID: 38091520 PMC: 10755757. DOI: 10.1021/acs.jafc.3c06887.

To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism.

Ianiro G, Niro A, Rosa L, Valenti P, Musci G, Cutone A Int J Mol Sci. 2023; 24(21).

PMID: 37958908 PMC: 10650157. DOI: 10.3390/ijms242115925.

Potential of Lactoferrin in the Treatment of Lung Diseases.

Kaczynska K, Jampolska M, Wojciechowski P, Sulejczak D, Andrzejewski K, Zajac D Pharmaceuticals (Basel). 2023; 16(2).

PMID: 37259341 PMC: 9960651. DOI: 10.3390/ph16020192.

Lactoferrin-Conjugated Nanoparticles as New Antivirals.

Krzyzowska M, Janicka M, Tomaszewska E, Ranoszek-Soliwoda K, Celichowski G, Grobelny J Pharmaceutics. 2022; 14(9).

PMID: 36145610 PMC: 9504495. DOI: 10.3390/pharmaceutics14091862.

References

Karav S, German J, Rouquie C, Le Parc A, Barile D . Studying Lactoferrin N-Glycosylation. Int J Mol Sci. 2017; 18(4). PMC: 5412451. DOI: 10.3390/ijms18040870. View

Ammendolia M, Agamennone M, Pietrantoni A, Lannutti F, Siciliano R, De Giulio B . Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus. Pathog Glob Health. 2012; 106(1):12-9. PMC: 4001507. DOI: 10.1179/2047773212Y.0000000004. View

Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K . Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess. 2003; 7(35):iii-iv, xi-xiii, 1-170. DOI: 10.3310/hta7350. View

Pandey R, Kim D, Woo J, Song J, Jang S, Kim J . Broad-spectrum neutralization of avian influenza viruses by sialylated human milk oligosaccharides: in vivo assessment of 3'-sialyllactose against H9N2 in chickens. Sci Rep. 2018; 8(1):2563. PMC: 5803236. DOI: 10.1038/s41598-018-20955-4. View

Carvalho C, Casseb S, Goncalves R, Silva E, Gomes A, Vasconcelos P . Bovine lactoferrin activity against Chikungunya and Zika viruses. J Gen Virol. 2017; 98(7):1749-1754. DOI: 10.1099/jgv.0.000849. View

Steel J, Lowen A, Pena L, Angel M, Solorzano A, Albrecht R . Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol. 2008; 83(4):1742-53. PMC: 2643794. DOI: 10.1128/JVI.01920-08. View

Margine I, Krammer F . Animal models for influenza viruses: implications for universal vaccine development. Pathogens. 2014; 3(4):845-74. PMC: 4282889. DOI: 10.3390/pathogens3040845. View

Hu Y, Meng X, Zhang F, Xiang Y, Wang J . The antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor. Emerg Microbes Infect. 2021; 10(1):317-330. PMC: 7919907. DOI: 10.1080/22221751.2021.1888660. View

Deyde V, Xu X, Bright R, Shaw M, Smith C, Zhang Y . Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis. 2007; 196(2):249-57. DOI: 10.1086/518936. View

10.

Marr A, Jenssen H, Moniri M, Hancock R, Pante N . Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochimie. 2008; 91(1):160-4. DOI: 10.1016/j.biochi.2008.05.016. View

11.

van der Vries E, Schutten M, Fraaij P, Boucher C, Osterhaus A . Influenza virus resistance to antiviral therapy. Adv Pharmacol. 2013; 67:217-46. DOI: 10.1016/B978-0-12-405880-4.00006-8. View

12.

Pietrantoni A, Dofrelli E, Tinari A, Ammendolia M, Puzelli S, Fabiani C . Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro. Biometals. 2010; 23(3):465-75. DOI: 10.1007/s10534-010-9323-3. View

13.

Salaris C, Scarpa M, Elli M, Bertolini A, Guglielmetti S, Pregliasco F . Protective Effects of Lactoferrin against SARS-CoV-2 Infection In Vitro. Nutrients. 2021; 13(2). PMC: 7911668. DOI: 10.3390/nu13020328. View

14.

Pietrantoni A, Ammendolia M, Superti F . Bovine lactoferrin: involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection. Biochem Cell Biol. 2012; 90(3):442-8. DOI: 10.1139/o11-072. View

15.

van Riel D, den Bakker M, Leijten L, Chutinimitkul S, Munster V, de Wit E . Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol. 2010; 176(4):1614-8. PMC: 2843453. DOI: 10.2353/ajpath.2010.090949. View

16.

Yamauchi K, Wakabayashi H, Shin K, Takase M . Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol. 2006; 84(3):291-6. DOI: 10.1139/o06-054. View

17.

Marchetti M, Trybala E, Superti F, Johansson M, Bergstrom T . Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology. 2004; 318(1):405-13. DOI: 10.1016/j.virol.2003.09.029. View

18.

Ogata M, Hidari K, Murata T, Shimada S, Kozaki W, Park E . Chemoenzymatic synthesis of sialoglycopolypeptides as glycomimetics to block infection by avian and human influenza viruses. Bioconjug Chem. 2009; 20(3):538-49. DOI: 10.1021/bc800460p. View

19.

Hara K, Ikeda M, Saito S, Matsumoto S, Numata K, Kato N . Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol Res. 2002; 24(3):228. DOI: 10.1016/s1386-6346(02)00088-8. View

20.

Rascon-Cruz Q, Espinoza-Sanchez E, Siqueiros-Cendon T, Nakamura-Bencomo S, Arevalo-Gallegos S, Iglesias-Figueroa B . Lactoferrin: A Glycoprotein Involved in Immunomodulation, Anticancer, and Antimicrobial Processes. Molecules. 2021; 26(1). PMC: 7795860. DOI: 10.3390/molecules26010205. View